HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit
Provided By PR Newswire
Last update: Jan 3, 2025
NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the "Class Period"), of the important January 17, 2025 lead plaintiff deadline.
Read more at prnewswire.com
